Veterinary Medicines

Utertab 2000 mg Intrauterine Tablet for Cattle

Authorised
  • Tetracycline hydrochloride
Download as PDF

Product identification

Medicine name:
Utertab 2000 mg intrauterine tablet for cattle
Utertab 2000 mg Intrauterine Tablet for Cattle
Active substance:
  • Tetracycline hydrochloride
Target species:
  • Cattle (lactating cow)
Route of administration:
  • Intrauterine use

Product details

Active substance and strength:
  • Tetracycline hydrochloride
    2000.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Intrauterine tablet
Withdrawal period by route of administration:
  • Intrauterine use
    • Cattle (lactating cow)
      • Milk
        96
        hour
      • Meat and offal
        10
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QG51AA02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • United Kingdom (Northern Ireland)
Package description:
  • (ID9) 500 Intrauterine tablet: unspecified outer container with 100 Blister (PolyVinyl Chloride; PolyEthylene; PolyVinylidene Chloride; Aluminium) each with 5 Intrauterine tablet
  • (ID8) 400 Intrauterine tablet: unspecified outer container with 80 Blister (PolyVinyl Chloride; PolyEthylene; PolyVinylidene Chloride; Aluminium) each with 5 Intrauterine tablet
  • (ID7) 300 Intrauterine tablet: unspecified outer container with 60 Blister (PolyVinyl Chloride; PolyEthylene; PolyVinylidene Chloride; Aluminium) each with 5 Intrauterine tablet
  • (ID6) 200 Intrauterine tablet: unspecified outer container with 40 Blister (PolyVinyl Chloride; PolyEthylene; PolyVinylidene Chloride; Aluminium) each with 5 Intrauterine tablet
  • (ID5) 100 Intrauterine tablet: unspecified outer container with 20 Blister (PolyVinyl Chloride; PolyEthylene; PolyVinylidene Chloride; Aluminium) each with 5 Intrauterine tablet
  • (ID4) 50 Intrauterine tablet: unspecified outer container with 10 Blister (PolyVinyl Chloride; PolyEthylene; PolyVinylidene Chloride; Aluminium) each with 5 Intrauterine tablet
  • (ID3) 20 Intrauterine tablet: unspecified outer container with 4 Blister (PolyVinyl Chloride; PolyEthylene; PolyVinylidene Chloride; Aluminium) each with 5 Intrauterine tablet
  • (ID2) 10 Intrauterine tablet: unspecified outer container with 2 Blister (PolyVinyl Chloride; PolyEthylene; PolyVinylidene Chloride; Aluminium) each with 5 Intrauterine tablet

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • aniMedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • aniMedica GmbH
  • aniMedica Herstellungs GmbH
Responsible authority:
  • The Veterinary Medicines Directorate
Authorisation number:
  • Vm 24745/4025
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0176/001
Concerned member states:
  • Bulgaria
  • Croatia
  • Hungary
  • Ireland
  • Italy
  • Netherlands
  • Poland
  • Portugal
  • Slovakia
  • Spain
  • United Kingdom (Northern Ireland)